12:00 AM
 | 
Feb 06, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Xoma, Servier sales and marketing update

Xoma gained U.S. commercialization rights to Servier's Aceon perindopril erbumine, as well as options to develop and commercialize up to three products in the U.S. combining...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >